| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 754 |
| 1 | PREDNISONE | 730 |
| 2 | ADALIMUMAB | 705 |
| 3 | METHOTREXATE | 689 |
| 4 | INFLIXIMAB | 599 |
| 5 | TACROLIMUS | 522 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 458 |
| 7 | TACROLIMUS OINTMENT 0.1% | 458 |
| 8 | ETANERCEPT | 457 |
| 9 | ASPIRIN | 438 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VEMURAFENIB | 239 | 0.0199 |
| 1 | ACITRETIN | 68 | 0.0138 |
| 2 | VISMODEGIB | 111 | 0.0124 |
| 3 | ERGOCALCIFEROL | 353 | 0.0119 |
| 4 | VORICONAZOLE | 225 | 0.0073 |
| 5 | GOLIMUMAB | 92 | 0.0073 |
| 6 | SIROLIMUS | 90 | 0.0066 |
| 7 | BASILIXIMAB | 74 | 0.0062 |
| 8 | HYDROXYUREA | 129 | 0.0060 |
| 9 | RUXOLITINIB | 326 | 0.0045 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1460 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 1247 |
| 2 | Kinase Inhibitor [EPC] | 1037 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 836 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 710 |
| 5 | Interleukin-23 Antagonist [EPC] | 551 |
| 6 | Janus Kinase Inhibitor [EPC] | 535 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 500 |
| 8 | Vitamin C [EPC] | 485 |
| 9 | Proton Pump Inhibitor [EPC] | 460 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 15 | 0.0218 |
| 1 | Photoactivated Radical Generator [EPC] | 2 | 0.0156 |
| 2 | Provitamin D2 Compound [EPC] | 353 | 0.0119 |
| 3 | Hedgehog Pathway Inhibitor [EPC] | 111 | 0.0118 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 55 | 0.0094 |
| 5 | Polyene Antimicrobial [EPC] | 3 | 0.0073 |
| 6 | CCR5 Co-receptor Antagonist [EPC] | 15 | 0.0065 |
| 7 | Interleukin-23 Antagonist [EPC] | 551 | 0.0053 |
| 8 | Antidiarrheal [EPC] | 1 | 0.0042 |
| 9 | Purine Antimetabolite [EPC] | 369 | 0.0037 |